Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Contineum Therapeutics (CTNM) Leases (2023 - 2025)

Contineum Therapeutics has reported Leases over the past 3 years, most recently at $4.8 million for Q3 2025.

  • Quarterly results put Leases at $4.8 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $4.8 million (changed N/A YoY), and the annual figure for FY2024 was $5.5 million, up 660.36%.
  • Leases for Q3 2025 was $4.8 million at Contineum Therapeutics, down from $5.0 million in the prior quarter.
  • Over the last five years, Leases for CTNM hit a ceiling of $5.5 million in Q4 2024 and a floor of $231000.0 in Q2 2024.
  • Median Leases over the past 3 years was $4.8 million (2025), compared with a mean of $3.1 million.
  • Biggest five-year swings in Leases: skyrocketed 660.36% in 2024 and later skyrocketed 2067.53% in 2025.
  • Contineum Therapeutics' Leases stood at $719000.0 in 2023, then skyrocketed by 660.36% to $5.5 million in 2024, then fell by 12.68% to $4.8 million in 2025.
  • The last three reported values for Leases were $4.8 million (Q3 2025), $5.0 million (Q2 2025), and $5.2 million (Q1 2025) per Business Quant data.